Overview

Reversing Endothelial and Diastolic Dysfunction and Improving Collagen Turnover in Diastolic Heart Failure

Status:
Terminated
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
The principle aim is to determine the efficacy of eplerenone in patients with diastolic heart failure to reverse cardiac remodeling and to improve diastolic function.
Phase:
Phase 4
Details
Lead Sponsor:
The Cleveland Clinic
Treatments:
Eplerenone